Key Takeaways:
Weight Watchers reported first-quarter revenue of $168 million and a 46 percent jump in clinical subscribers, a mixed result as the company pivots to a more health-focused model.
“We remain confident in our strategy to build the industry-leading weight health platform,” Sima Sistani, CEO of WW International, said in a statement.
The company's stock performance was not immediately available. The reaffirmed full-year guidance and debt reduction plan aim to reassure investors of the company's long-term financial health as it navigates a challenging transition.
The company also announced a fully subscribed debt prepayment solicitation as part of actions expected to reduce its debt by $42 million. While clinical subscription revenue saw a 32 percent increase year-over-year to $39 million, the company did not disclose the year-over-year change for its total revenue of $168 million. Figures for earnings per share and a comparison to analyst consensus were not available in the initial announcement.
The growth in the clinical segment suggests the company's strategic shift is gaining some traction. Investors will be closely watching the next quarter's results to see if this growth can offset declines in the traditional subscriber base and lead to a sustained turnaround.
This article is for informational purposes only and does not constitute investment advice.
